期刊文献+

移植领域中人巨细胞病毒感染的关注点与对策 被引量:6

原文传递
导出
摘要 组织器官和造血干细胞移植为终末期器官衰竭、恶性血液病、肿瘤等疾病患者带来了第二次生命,而巨细胞病毒(CMV)感染却严重威胁移植受者的生命,并影响其长期存活,已引起人们的高度关注。 我国人群CMV感染率高达90%,发生CMV活动并发展为CMV病主要出现在宿主免疫功能低下或受损的人群中。机体免疫功能健全状态下,CMV感染受监控,其表现为亚临床或自限性单核细胞增多样综合征,无碍健康。
作者 季育华
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2008年第3期188-189,共2页 Chinese Journal of Organ Transplantation
  • 相关文献

参考文献14

  • 1Pancholi P, Wu F, Della-Latta P. Rapid detection of cytomegalovirus infection in transplant patients. Expert Rev Mol Diagn, 2004, 4(2):231-242.
  • 2Lurain NS, Bhorade SM, Pursell KJ, et al. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients. J Infect Dis, 2002,186(6): 760-768.
  • 3Chou S, Waldemer RH, Senters AE, et al. Cytomegalovirus UL97 phosphotransferase mutation that affect susceptibility to ganciclovir. J Infect Dis, 2002, 185(2) : 162-169.
  • 4Ban Hock Tan. CMV prophylaxis-to do or not to do, that is the question. Nephrol Dial Transplant, 2006, 21 (7) : 1761-1763.
  • 5Jennifer E, Marfori C, Maurice M, et al. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients. J Clin Virol, 2007, 38(2): 120-125.
  • 6Jabs DA, Martin BK, Forman MS, et al. Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis. J Infec Dis, 2001, 183(2):333-337.
  • 7Locarnini S, Hatzakis A, Heathcote J, et al. Management of antiviral resistance in patients with chronic hepatitis 13. Antivir Ther, 2004, 9(5):679-693.
  • 8Nichols W, Boeckh M. Cytomegalovirus infections. Curr Treat Options Infect Dis, 2001, 3:78-91.
  • 9Jabs DA, Marktin BK, Ricks MO, et al. Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis; correlation of genotypic methods with viral phenotype and clinical outcome. J Infect Dis, 2006, 193(12) :1728-1737.
  • 10Sagedal S, Hartmann A, Rollay H. The impact of early cytomegalovirus infection and disease in renal transplant recipients. Clin Microbiol Infect, 2005, 11 (7) : 518-530.

同被引文献55

  • 1李长贵,周铁群,王剑锋,李娟.人巨细胞病毒低基质蛋白pp65亲水性片段的克隆与表达[J].中华检验医学杂志,2005,28(7):703-705. 被引量:4
  • 2刘雅峰,郑克立,王长希,陈立中,戴宇平,徐鸿绪,陈俊星.器官移植受者巨细胞病毒感染检测的临床意义[J].中国现代医学杂志,2006,16(1):37-39. 被引量:12
  • 3Chou S, Waldemer RH, Senters AE, et al. Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir [ J ]. J Infect Dis, 2002, 185(2) :162-169.
  • 4Pancholi P, Wu F, Della-Latta P. Rapid detection of Cytomegalovirus infection in transplant patients [ J ]. Expert Rev Mol Diagn, 2004, 4(2) :231-242.
  • 5Lurain NS, Weinberg A, Crumpacker CS, et al. Se-quencing of Cytomegalovirus UL97 gene for genotypic antiviral resistance testing [ J ]. Antimicrob Agents Chemother,2001 ; 45 (10) :2775-2780.
  • 6Jabs DA, Marktin BK, Ricks MO, et al. Detection of ganciclovir resistance in patients with AIDS and Cyto- megalovirus retinitis correlation of genotypic methods with viral phenotype and clinical outcome [J].J Infect Dis,2006, 193 (12) : 1728-1737.
  • 7Boivin G,Chou S, Quirk MR, et al. Detection of ganciclovir resistance mutations quantitation of Cytomegalovirus (CMV) DNA in leukocytes of patients with fa-tal disseminated CMV disease [ J ]. J Infect Dis, 1996, 173 (3) :523-528.
  • 8Boivin G, Goyette N, Gilbert C, et al. Absence of Cy-tomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of sol- id-organ transplant recipients[ J]. J Infect Dis, 2004, 189(9) :1615-1618.
  • 9Chou S. Antiviral drug resistance in Human cytomegalovirus [ J ]. Transpl Infect Dis, 1999, 1 (2) : 105-114.
  • 10Yan SS, Fedorko DP. Recent advances in laboratory diagnosis of Human cytomegalovirus infection[J]. Clin Applied Immunol Rev, 2002, 2(2):155-167.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部